The global market for AI in Biopharma was valued at US$ 1033 million in the year 2024 and is projected to reach a revised size of US$ 1971 million by 2031, growing at a CAGR of 10.6% during the forecast period.

AI in Biopharma Market

AI in Biopharma refers to the application of Artificial Intelligence (AI) and its sub-fields, particularly Machine Learning (ML) and Deep Learning (DL), to transform and accelerate processes across the entire biopharmaceutical value chain. This includes leveraging algorithms to analyze vast and complex biological, chemical, genetic, and clinical datasets to make predictions, recommendations, and automate tasks. The primary goal is to significantly improve the efficiency, speed, and success rate of drug discovery, target identification, compound optimization, clinical trial design, manufacturing, and personalized medicine, ultimately reducing costs and bringing novel therapies to patients faster.

North American market for AI in Biopharma is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for AI in Biopharma is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for AI in Biopharma in Drug Development is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of AI in Biopharma include Recursion Pharmaceuticals, Exscientia, XtalPi, Schrödinger, Owkin, Evogene, BioNTech, MedySapiens, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for AI in Biopharma, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI in Biopharma.

The AI in Biopharma market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global AI in Biopharma market comprehensively. Regional market sizes, concerning products by Type, by Application, by Research Direction and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the AI in Biopharma companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of AI in Biopharma Market Report

Report Metric	Details
Report Name	AI in Biopharma Market
Accounted market size in year	US$ 1033 million
Forecasted market size in 2031	US$ 1971 million
CAGR	10.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Machine Learning (ML) & Deep Learning (DL) Natural Language Processing (NLP) Others
Segment by Research Direction	Drug Discovery & Development Genomics & Precision Medicine Medical Imaging & Diagnostics Others
Segment by Application	Drug Development Disease Diagnosis and Treatment Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Recursion Pharmaceuticals, Exscientia, XtalPi, Schrödinger, Owkin, Evogene, BioNTech, MedySapiens
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Research Direction etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AI in Biopharma company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is AI in Biopharma Market growing?

Ans: The AI in Biopharma Market witnessing a CAGR of 10.6% during the forecast period 2025-2031.

What is the AI in Biopharma Market size in 2031?

Ans: The AI in Biopharma Market size in 2031 will be US$ 1971 million.

Who are the main players in the AI in Biopharma Market report?

Ans: The main players in the AI in Biopharma Market are Recursion Pharmaceuticals, Exscientia, XtalPi, Schrödinger, Owkin, Evogene, BioNTech, MedySapiens

What are the Application segmentation covered in the AI in Biopharma Market report?

Ans: The Applications covered in the AI in Biopharma Market report are Drug Development, Disease Diagnosis and Treatment, Other

What are the Type segmentation covered in the AI in Biopharma Market report?

Ans: The Types covered in the AI in Biopharma Market report are Machine Learning (ML) & Deep Learning (DL), Natural Language Processing (NLP), Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global AI in Biopharma Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Machine Learning (ML) & Deep Learning (DL)

1.2.3 Natural Language Processing (NLP)

1.2.4 Others

1.3 Market by Research Direction

1.3.1 Global AI in Biopharma Market Size Growth Rate by Research Direction: 2020 VS 2024 VS 2031

1.3.2 Drug Discovery & Development

1.3.3 Genomics & Precision Medicine

1.3.4 Medical Imaging & Diagnostics

1.3.5 Others

1.4 Market by Application

1.4.1 Global AI in Biopharma Market Growth by Application: 2020 VS 2024 VS 2031

1.4.2 Drug Development

1.4.3 Disease Diagnosis and Treatment

1.4.4 Other

1.5 Assumptions and Limitations

1.6 Study Objectives

1.7 Years Considered

2 Global Growth Trends

2.1 Global AI in Biopharma Market Perspective (2020-2031)

2.2 Global AI in Biopharma Growth Trends by Region

2.2.1 Global AI in Biopharma Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 AI in Biopharma Historic Market Size by Region (2020-2025)

2.2.3 AI in Biopharma Forecasted Market Size by Region (2026-2031)

2.3 AI in Biopharma Market Dynamics

2.3.1 AI in Biopharma Industry Trends

2.3.2 AI in Biopharma Market Drivers

2.3.3 AI in Biopharma Market Challenges

2.3.4 AI in Biopharma Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top AI in Biopharma Players by Revenue

3.1.1 Global Top AI in Biopharma Players by Revenue (2020-2025)

3.1.2 Global AI in Biopharma Revenue Market Share by Players (2020-2025)

3.2 Global Top AI in Biopharma Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by AI in Biopharma Revenue

3.4 Global AI in Biopharma Market Concentration Ratio

3.4.1 Global AI in Biopharma Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by AI in Biopharma Revenue in 2024

3.5 Global Key Players of AI in Biopharma Head office and Area Served

3.6 Global Key Players of AI in Biopharma, Product and Application

3.7 Global Key Players of AI in Biopharma, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 AI in Biopharma Breakdown Data by Type

4.1 Global AI in Biopharma Historic Market Size by Type (2020-2025)

4.2 Global AI in Biopharma Forecasted Market Size by Type (2026-2031)

5 AI in Biopharma Breakdown Data by Application

5.1 Global AI in Biopharma Historic Market Size by Application (2020-2025)

5.2 Global AI in Biopharma Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America AI in Biopharma Market Size (2020-2031)

6.2 North America AI in Biopharma Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America AI in Biopharma Market Size by Country (2020-2025)

6.4 North America AI in Biopharma Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe AI in Biopharma Market Size (2020-2031)

7.2 Europe AI in Biopharma Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe AI in Biopharma Market Size by Country (2020-2025)

7.4 Europe AI in Biopharma Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific AI in Biopharma Market Size (2020-2031)

8.2 Asia-Pacific AI in Biopharma Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific AI in Biopharma Market Size by Region (2020-2025)

8.4 Asia-Pacific AI in Biopharma Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America AI in Biopharma Market Size (2020-2031)

9.2 Latin America AI in Biopharma Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America AI in Biopharma Market Size by Country (2020-2025)

9.4 Latin America AI in Biopharma Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa AI in Biopharma Market Size (2020-2031)

10.2 Middle East & Africa AI in Biopharma Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa AI in Biopharma Market Size by Country (2020-2025)

10.4 Middle East & Africa AI in Biopharma Market Size by Country (2026-2031)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Recursion Pharmaceuticals

11.1.1 Recursion Pharmaceuticals Company Details

11.1.2 Recursion Pharmaceuticals Business Overview

11.1.3 Recursion Pharmaceuticals AI in Biopharma Introduction

11.1.4 Recursion Pharmaceuticals Revenue in AI in Biopharma Business (2020-2025)

11.1.5 Recursion Pharmaceuticals Recent Development

11.2 Exscientia

11.2.1 Exscientia Company Details

11.2.2 Exscientia Business Overview

11.2.3 Exscientia AI in Biopharma Introduction

11.2.4 Exscientia Revenue in AI in Biopharma Business (2020-2025)

11.2.5 Exscientia Recent Development

11.3 XtalPi

11.3.1 XtalPi Company Details

11.3.2 XtalPi Business Overview

11.3.3 XtalPi AI in Biopharma Introduction

11.3.4 XtalPi Revenue in AI in Biopharma Business (2020-2025)

11.3.5 XtalPi Recent Development

11.4 Schrödinger

11.4.1 Schrödinger Company Details

11.4.2 Schrödinger Business Overview

11.4.3 Schrödinger AI in Biopharma Introduction

11.4.4 Schrödinger Revenue in AI in Biopharma Business (2020-2025)

11.4.5 Schrödinger Recent Development

11.5 Owkin

11.5.1 Owkin Company Details

11.5.2 Owkin Business Overview

11.5.3 Owkin AI in Biopharma Introduction

11.5.4 Owkin Revenue in AI in Biopharma Business (2020-2025)

11.5.5 Owkin Recent Development

11.6 Evogene

11.6.1 Evogene Company Details

11.6.2 Evogene Business Overview

11.6.3 Evogene AI in Biopharma Introduction

11.6.4 Evogene Revenue in AI in Biopharma Business (2020-2025)

11.6.5 Evogene Recent Development

11.7 BioNTech

11.7.1 BioNTech Company Details

11.7.2 BioNTech Business Overview

11.7.3 BioNTech AI in Biopharma Introduction

11.7.4 BioNTech Revenue in AI in Biopharma Business (2020-2025)

11.7.5 BioNTech Recent Development

11.8 MedySapiens

11.8.1 MedySapiens Company Details

11.8.2 MedySapiens Business Overview

11.8.3 MedySapiens AI in Biopharma Introduction

11.8.4 MedySapiens Revenue in AI in Biopharma Business (2020-2025)

11.8.5 MedySapiens Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Artificial Intelligence

Recursion Pharmaceuticals

List of Tables

Table 1. Global AI in Biopharma Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Machine Learning (ML) & Deep Learning (DL)

Table 3. Key Players of Natural Language Processing (NLP)

Table 4. Key Players of Others

Table 5. Global AI in Biopharma Market Size Growth Rate by Research Direction (US$ Million): 2020 VS 2024 VS 2031

Table 6. Key Players of Drug Discovery & Development

Table 7. Key Players of Genomics & Precision Medicine

Table 8. Key Players of Medical Imaging & Diagnostics

Table 9. Key Players of Others

Table 10. Global AI in Biopharma Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 11. Global AI in Biopharma Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 12. Global AI in Biopharma Market Size by Region (2020-2025) & (US$ Million)

Table 13. Global AI in Biopharma Market Share by Region (2020-2025)

Table 14. Global AI in Biopharma Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 15. Global AI in Biopharma Market Share by Region (2026-2031)

Table 16. AI in Biopharma Market Trends

Table 17. AI in Biopharma Market Drivers

Table 18. AI in Biopharma Market Challenges

Table 19. AI in Biopharma Market Restraints

Table 20. Global AI in Biopharma Revenue by Players (2020-2025) & (US$ Million)

Table 21. Global AI in Biopharma Market Share by Players (2020-2025)

Table 22. Global Top AI in Biopharma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI in Biopharma as of 2024)

Table 23. Ranking of Global Top AI in Biopharma Companies by Revenue (US$ Million) in 2024

Table 24. Global 5 Largest Players Market Share by AI in Biopharma Revenue (CR5 and HHI) & (2020-2025)

Table 25. Global Key Players of AI in Biopharma, Headquarters and Area Served

Table 26. Global Key Players of AI in Biopharma, Product and Application

Table 27. Global Key Players of AI in Biopharma, Date of Enter into This Industry

Table 28. Mergers & Acquisitions, Expansion Plans

Table 29. Global AI in Biopharma Market Size by Type (2020-2025) & (US$ Million)

Table 30. Global AI in Biopharma Revenue Market Share by Type (2020-2025)

Table 31. Global AI in Biopharma Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 32. Global AI in Biopharma Revenue Market Share by Type (2026-2031)

Table 33. Global AI in Biopharma Market Size by Application (2020-2025) & (US$ Million)

Table 34. Global AI in Biopharma Revenue Market Share by Application (2020-2025)

Table 35. Global AI in Biopharma Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 36. Global AI in Biopharma Revenue Market Share by Application (2026-2031)

Table 37. North America AI in Biopharma Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. North America AI in Biopharma Market Size by Country (2020-2025) & (US$ Million)

Table 39. North America AI in Biopharma Market Size by Country (2026-2031) & (US$ Million)

Table 40. Europe AI in Biopharma Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Europe AI in Biopharma Market Size by Country (2020-2025) & (US$ Million)

Table 42. Europe AI in Biopharma Market Size by Country (2026-2031) & (US$ Million)

Table 43. Asia-Pacific AI in Biopharma Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 44. Asia-Pacific AI in Biopharma Market Size by Region (2020-2025) & (US$ Million)

Table 45. Asia-Pacific AI in Biopharma Market Size by Region (2026-2031) & (US$ Million)

Table 46. Latin America AI in Biopharma Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Latin America AI in Biopharma Market Size by Country (2020-2025) & (US$ Million)

Table 48. Latin America AI in Biopharma Market Size by Country (2026-2031) & (US$ Million)

Table 49. Middle East & Africa AI in Biopharma Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 50. Middle East & Africa AI in Biopharma Market Size by Country (2020-2025) & (US$ Million)

Table 51. Middle East & Africa AI in Biopharma Market Size by Country (2026-2031) & (US$ Million)

Table 52. Recursion Pharmaceuticals Company Details

Table 53. Recursion Pharmaceuticals Business Overview

Table 54. Recursion Pharmaceuticals AI in Biopharma Product

Table 55. Recursion Pharmaceuticals Revenue in AI in Biopharma Business (2020-2025) & (US$ Million)

Table 56. Recursion Pharmaceuticals Recent Development

Table 57. Exscientia Company Details

Table 58. Exscientia Business Overview

Table 59. Exscientia AI in Biopharma Product

Table 60. Exscientia Revenue in AI in Biopharma Business (2020-2025) & (US$ Million)

Table 61. Exscientia Recent Development

Table 62. XtalPi Company Details

Table 63. XtalPi Business Overview

Table 64. XtalPi AI in Biopharma Product

Table 65. XtalPi Revenue in AI in Biopharma Business (2020-2025) & (US$ Million)

Table 66. XtalPi Recent Development

Table 67. Schrödinger Company Details

Table 68. Schrödinger Business Overview

Table 69. Schrödinger AI in Biopharma Product

Table 70. Schrödinger Revenue in AI in Biopharma Business (2020-2025) & (US$ Million)

Table 71. Schrödinger Recent Development

Table 72. Owkin Company Details

Table 73. Owkin Business Overview

Table 74. Owkin AI in Biopharma Product

Table 75. Owkin Revenue in AI in Biopharma Business (2020-2025) & (US$ Million)

Table 76. Owkin Recent Development

Table 77. Evogene Company Details

Table 78. Evogene Business Overview

Table 79. Evogene AI in Biopharma Product

Table 80. Evogene Revenue in AI in Biopharma Business (2020-2025) & (US$ Million)

Table 81. Evogene Recent Development

Table 82. BioNTech Company Details

Table 83. BioNTech Business Overview

Table 84. BioNTech AI in Biopharma Product

Table 85. BioNTech Revenue in AI in Biopharma Business (2020-2025) & (US$ Million)

Table 86. BioNTech Recent Development

Table 87. MedySapiens Company Details

Table 88. MedySapiens Business Overview

Table 89. MedySapiens AI in Biopharma Product

Table 90. MedySapiens Revenue in AI in Biopharma Business (2020-2025) & (US$ Million)

Table 91. MedySapiens Recent Development

Table 92. Research Programs/Design for This Report

Table 93. Key Data Information from Secondary Sources

Table 94. Key Data Information from Primary Sources

Table 95. Authors List of This Report

List of Figures

Figure 1. AI in Biopharma Picture

Figure 2. Global AI in Biopharma Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global AI in Biopharma Market Share by Type: 2024 VS 2031

Figure 4. Machine Learning (ML) & Deep Learning (DL) Features

Figure 5. Natural Language Processing (NLP) Features

Figure 6. Others Features

Figure 7. Global AI in Biopharma Market Size Comparison by Research Direction (2020-2031) & (US$ Million)

Figure 8. Drug Discovery & Development Features

Figure 9. Genomics & Precision Medicine Features

Figure 10. Medical Imaging & Diagnostics Features

Figure 11. Others Features

Figure 12. Global AI in Biopharma Market Size by Application (2020-2031) & (US$ Million)

Figure 13. Global AI in Biopharma Market Share by Application: 2024 VS 2031

Figure 14. Drug Development Case Studies

Figure 15. Disease Diagnosis and Treatment Case Studies

Figure 16. Other Case Studies

Figure 17. AI in Biopharma Report Years Considered

Figure 18. Global AI in Biopharma Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 19. Global AI in Biopharma Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 20. Global AI in Biopharma Market Share by Region: 2024 VS 2031

Figure 21. Global AI in Biopharma Market Share by Players in 2024

Figure 22. Global AI in Biopharma Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 23. The Top 10 and 5 Players Market Share by AI in Biopharma Revenue in 2024

Figure 24. North America AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. North America AI in Biopharma Market Share by Country (2020-2031)

Figure 26. United States AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Canada AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Europe AI in Biopharma Market Share by Country (2020-2031)

Figure 30. Germany AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. France AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. U.K. AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Italy AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Russia AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Ireland AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Asia-Pacific AI in Biopharma Market Share by Region (2020-2031)

Figure 38. China AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Japan AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. South Korea AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Southeast Asia AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. India AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Australia & New Zealand AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Latin America AI in Biopharma Market Share by Country (2020-2031)

Figure 46. Mexico AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Brazil AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Middle East & Africa AI in Biopharma Market Share by Country (2020-2031)

Figure 50. Israel AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. UAE AI in Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Recursion Pharmaceuticals Revenue Growth Rate in AI in Biopharma Business (2020-2025)

Figure 54. Exscientia Revenue Growth Rate in AI in Biopharma Business (2020-2025)

Figure 55. XtalPi Revenue Growth Rate in AI in Biopharma Business (2020-2025)

Figure 56. Schrödinger Revenue Growth Rate in AI in Biopharma Business (2020-2025)

Figure 57. Owkin Revenue Growth Rate in AI in Biopharma Business (2020-2025)

Figure 58. Evogene Revenue Growth Rate in AI in Biopharma Business (2020-2025)

Figure 59. BioNTech Revenue Growth Rate in AI in Biopharma Business (2020-2025)

Figure 60. MedySapiens Revenue Growth Rate in AI in Biopharma Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-6Q20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-35Z19949

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26E19785

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions